Coherus Oncology Insider Trades
NASDAQ: CHRSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Coherus Oncology insider activity
Over the last 12 months, Coherus Oncology insiders reported 11 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Ryan Michael Lee (Director) reporting a transaction in 30,000 shares on Jun 5, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CHRS's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
CHRS insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 5, 2026 | Newton Charles W.Director | Award | 30,000 | — | Form 4 |
| Jun 5, 2026 | Wahlstrom MatsDirector | Award | 30,000 | — | Form 4 |
| Jun 5, 2026 | Newcomer Lee NisleyDirector | Award | 30,000 | — | Form 4 |
| Jun 5, 2026 | Karachun Rita ADirector | Award | 30,000 | — | Form 4 |
| Jun 5, 2026 | Satvat Ali J.Director | Award | 30,000 | — | Form 4 |
| Jun 5, 2026 | O'Donnell-Tormey JillDirector | Award | 30,000 | — | Form 4 |
| Jun 5, 2026 | Ryan Michael LeeDirector | Award | 30,000 | — | Form 4 |
| Jan 23, 2026 | Lanfear Dennis MPresident & CEO | Award | 375,000 | — | Form 4 |
| Jan 22, 2026 | McMichael Bryan JChief Financial Officer | Award | 112,500 | — | Form 4 |
| Jan 20, 2026 | Lanfear Dennis MPresident & CEO | Tax withholding | 11,839 | $18.35K | Form 4 |
| Jan 20, 2026 | McMichael Bryan JChief Financial Officer | Tax withholding | 1,715 | $2.66K | Form 4 |
| May 23, 2025 | Wahlstrom MatsDirector | Sale | 99,988 | $73.88K | Form 4 |
| Jan 20, 2025 | Reider PaulChief Commercial Officer | Tax withholding | 4,858 | $6.75K | Form 4 |
| Jan 20, 2025 | Lanfear Dennis MPresident & CEO | Tax withholding | 11,810 | $16.42K | Form 4 |
| Jan 20, 2025 | McMichael Bryan JChief Financial Officer | Tax withholding | 1,711 | $2.38K | Form 4 |
| Jan 7, 2025 | McMichael Bryan JChief Financial Officer | Tax withholding | 1,711 | $2.69K | Form 4 |
| Jan 4, 2025 | Lanfear Dennis MPresident & CEO | Tax withholding | 11,810 | $19.60K | Form 4 |
| Jan 4, 2025 | Reider PaulChief Commercial Officer | Tax withholding | 2,277 | $3.78K | Form 4 |
| Dec 13, 2024 | Reider PaulChief Commercial Officer | Tax withholding | 2,073 | $3.34K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4